Literature DB >> 8452947

Malaria in splenectomized patients: report of four cases and review.

S Looareesuwan1, P Suntharasamai, H K Webster, M Ho.   

Abstract

The spleen plays a central role in host defense against malaria in animals. Its role in human malaria is less well established. The spleen may contribute to protection against human malaria by mediating humoral or cellular immune responses or by clearing both rheologically and immunologically altered host erythrocytes. This report describes Plasmodium falciparum and Plasmodium vivax infections that occurred after splenectomy in one nonimmune and three partially immune Thai adults. The clinical course was uncomplicated for all four patients, and parasite clearance was delayed only in the nonimmune patient. In three patients with falciparum malaria, humoral and cellular immune responses to blood-stage antigens during the acute infection and convalescence were similar to those of individuals whose spleens were intact. These findings suggest that the spleen may not be essential for the processes leading to parasite clearance in partially immune, splenectomized patients. Further studies on the course of malarial infections in splenectomized patients are crucial for clarifying the role of the spleen in host defense against human malaria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452947     DOI: 10.1093/clind/16.3.361

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Epigenetics in Plasmodium: what do we really know?

Authors:  Catherine J Merrick; Manoj T Duraisingh
Journal:  Eukaryot Cell       Date:  2010-06-18

2.  The incidence of malaria after splenectomy in Papua New Guinea.

Authors:  K E Boone; D A Watters
Journal:  BMJ       Date:  1995-11-11

Review 3.  The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology.

Authors:  Pierre A Buffet; Innocent Safeukui; Guillaume Deplaine; Valentine Brousse; Virginie Prendki; Marc Thellier; Gareth D Turner; Odile Mercereau-Puijalon
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

4.  Rodent blood-stage Plasmodium survive in dendritic cells that infect naive mice.

Authors:  Michelle N Wykes; Jason G Kay; Anthony Manderson; Xue Q Liu; Darren L Brown; Derek J Richard; Jiraprapa Wipasa; Suhua H Jiang; Malcolm K Jones; Chris J Janse; Andrew P Waters; Susan K Pierce; Louis H Miller; Jennifer L Stow; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

5.  Post Splenectomy Outcome in β-Thalassemia.

Authors:  Rashid H Merchant; Ami R Shah; Javed Ahmad; Alka Karnik; Nooralam Rai
Journal:  Indian J Pediatr       Date:  2015-06-23       Impact factor: 1.967

Review 6.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Interaction of malaria with a common form of severe thalassemia in an Asian population.

Authors:  A O'Donnell; A Premawardhena; M Arambepola; R Samaranayake; S J Allen; T E A Peto; C A Fisher; J Cook; P H Corran; Nancy F Olivieri; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

8.  Differential requirements for an intact spleen in induction and expression of B-cell-dependent immunity to Plasmodium chabaudi AS.

Authors:  G S Yap; M M Stevenson
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Severe malaria in a splenectomised Gabonese woman.

Authors:  Martin P Grobusch; Steffen Borrmann; Justin Omva; Saadou Issifou; Peter G Kremsner
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

10.  Absence of erythrocyte sequestration and lack of multicopy gene family expression in Plasmodium falciparum from a splenectomized malaria patient.

Authors:  Anna Bachmann; Claudia Esser; Michaela Petter; Sabine Predehl; Vera von Kalckreuth; Stefan Schmiedel; Iris Bruchhaus; Egbert Tannich
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.